Free Trial

Glaukos (GKOS) Stock Forecast & Price Target

$123.31
+2.22 (+1.83%)
(As of 07/15/2024 ET)

Glaukos - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$119.18
-3.35% Downside
High Forecast$132.00
Average Forecast$119.18
Low Forecast$100.00
TypeCurrent Forecast
7/16/23 to 7/15/24
1 Month Ago
6/16/23 to 6/15/24
3 Months Ago
4/17/23 to 4/16/24
1 Year Ago
7/16/22 to 7/16/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
9 Buy rating(s)
7 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$119.18$112.27$99.80$67.78
Forecasted Upside-3.35% Downside11.79% Upside14.17% Upside21.72% Upside
Get Glaukos Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

GKOS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GKOS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Glaukos Stock vs. The Competition

TypeGlaukosMedical CompaniesS&P 500
Consensus Rating Score
2.73
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-2.87% Downside988.78% Upside8.89% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/15/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$100.00 ➝ $120.00-1.70%
7/15/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$112.00 ➝ $131.00+7.31%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Wuensch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$130.00 ➝ $132.00+8.50%
6/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$110.00 ➝ $130.00+16.53%
6/3/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$110.00 ➝ $120.00+5.15%
5/6/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$84.00 ➝ $125.00+17.36%
5/2/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$108.00 ➝ $110.00+3.58%
5/2/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$120.00 ➝ $125.00+20.38%
5/2/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$108.00 ➝ $113.00+14.33%
4/11/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $100.00+0.29%
12/22/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$90.00 ➝ $105.00+23.53%
5/4/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
2/22/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kaczor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
12/28/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$69.00 ➝ $68.00+66.58%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:06 AM ET.

GKOS Forecast - Frequently Asked Questions

What is Glaukos' forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Glaukos is $119.18, with a high forecast of $132.00 and a low forecast of $100.00.

Should I buy or sell Glaukos stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Glaukos in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GKOS shares.

Does Glaukos's stock price have much upside?

According to analysts, Glaukos's stock has a predicted upside of 10.02% based on their 12-month stock forecasts.

Has Glaukos been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, Glaukos's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover Glaukos?
Do Wall Street analysts like Glaukos more than its competitors?

Analysts like Glaukos more than other "medical" companies. The consensus rating score for Glaukos is 2.73 while the average consensus rating score for "medical" companies is 2.71. Learn more on how GKOS compares to other companies.


This page (NYSE:GKOS) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners